Clinical Trials Browser

Phase 3 × Essential Hypertension × Clear all

NCT01151410 2016-03-07

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Phase 3 Completed

208 enrolled 10 charts

Essential Hypertension, Hypertension, Neoplasm Metastasis